infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 5 of 5 articles from: HCV and HBV

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • No Consistent Pattern of HBV Reactivation With Direct-acting Antivirals for HCV

    Medscape (requires free registration) / 27 April 2017

  • European Medicines Agency warns of risk of hepatitis B re-activation with direct-acting antivirals for hepatitis C

    EMA / 07 December 2016

  • HCV Drugs May Reactivate HBV, FDA Warns

    Medscape (free registration required) / 06 October 2016

  • Hepatitis B and C co-infection linked to worse liver fibrosis than hepatitis B alone

    Liz Highleyman / 01 June 2015

    People with both hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infection may experience more rapid and severe liver disease progression than those with hepatitis B alone, though HBV/HCV co-infection did ...

  • HBV/HCV coinfection linked to younger age, HIV, male sex

    Healio Hepatology / 17 April 2013

← First1Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
      • Transmission and prevention
      • Diagnosis and monitoring
      • Disease course and symptoms
      • Treatment
      • HIV and HBV
      • HCV and HBV
      • Hepatitis delta
      • Living with HBV
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//